Progress in diagnosis and treatment of diabetic nephropathy

Home > Archive>Volume 28, Issue 8, 2020 >688-691, 706

Progress in diagnosis and treatment of diabetic nephropathy
DOI:
                        
                    
CSTR:
                        [cstr]
                    
Author:
                        LIU YikaiLIU Yikai
Department of Metabolism and Endocrinology & Key Laboratory of Diabetes Immunology, Ministry of Education & National Clinical Research Center for Metabolic Diseases, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
LUO ShuomingLUO Shuoming
Department of Metabolism and Endocrinology & Key Laboratory of Diabetes Immunology, Ministry of Education & National Clinical Research Center for Metabolic Diseases, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
DENG MinDENG Min
Department of Metabolism and Endocrinology & Key Laboratory of Diabetes Immunology, Ministry of Education & National Clinical Research Center for Metabolic Diseases, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
ZHOU ZhiguangZHOU Zhiguang
Department of Metabolism and Endocrinology & Key Laboratory of Diabetes Immunology, Ministry of Education & National Clinical Research Center for Metabolic Diseases, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:Department of Metabolism and Endocrinology & Key Laboratory of Diabetes Immunology, Ministry of Education & National Clinical Research Center for Metabolic Diseases, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China)
Clc Number:R5
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Diabetes is a group of metabolic diseases characterized by disorders of glucose metabolism, which are caused by a variety of environmental and genetic causes. Diabetic nephropathy (DN) is the most common and severe chronic comorbidity in patients with diabetes. At present, diabetic nephropathy accounts for about 40% of diabetic patients, and is the main cause of chronic kidney disease (CKD) worldwide. At present, China is already the world's largest country with diabetes and a country with diabetic nephropathy. This article reviews the new research progress in the diagnosis and treatment of diabetic nephropathy. Designed to provide the latest information on DN diagnosis and treatment.

Key words:diabetes; diabetic nephropathy; risk factor; biomarker

Get Citation

LIU Yikai, LUO Shuoming, DENG Min, ZHOU Zhiguang. Progress in diagnosis and treatment of diabetic nephropathy[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(8):688-691, 706.

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

History

Received:April 10,2020
Revised:May 15,2020
Adopted:
Online: July 03,2020
Published:

Policies & Instructions

Get Citation

Share

Article Metrics

History

Article QR Code